Open AccessThis article is
- freely available
Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases
Division of Medical Oncology, Department of Medicine, The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa Hospital Research Institute, Box 900, 501 Smyth Road, Ottawa, Ontario K1H8L6, Canada
Centre for Cancer Therapeutics, The Ottawa Hospital Research Institute, Departments of Medicine & Biochemistry Microbiology & Immunology, University of Ottawa, Box 926, 501 Smyth Road, Ottawa, Ontario K1H8L6, Canada
Centre for Practice Changing Research & Ottawa Hospital Research Institute, Box 201, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada
* Author to whom correspondence should be addressed.
Received: 24 June 2013; in revised form: 25 July 2013 / Accepted: 29 July 2013 / Published: 19 August 2013
Abstract: Despite advances in adjuvant therapy for breast cancer, bone remains the most common site of recurrence. The goal of therapy for these patients is palliative and focused on maximizing the duration and quality of their life, while concurrently minimizing any disease or treatment-related complications. Bone metastases predispose patients to reduced survival, pain, impaired quality of life and the development of skeletal-related events. With an increased understanding of the pathophysiology of bone metastasis, effective treatments for their management have evolved and are now in widespread clinical use. This article will discuss the pathogenesis of bone metastases and review the key clinical evidence for the efficacy and safety of currently available systemic bone-targeted therapies in breast cancer patients with an emphasis on bisphosphonates and the receptor activator of nuclear factor kappa B ligand (RANKL) inhibitors. We will also discuss novel strategies and therapies currently in development.
Keywords: bone metastases; bone-targeted therapy; skeletal-related events; bisphosphonates; denosumab
Citations to this Article
Cite This Article
MDPI and ACS Style
Simos, D.; Addison, C.L.; Kuchuk, I.; Hutton, B.; Mazzarello, S.; Clemons, M. Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases. J. Clin. Med. 2013, 2, 67-88.
Simos D, Addison CL, Kuchuk I, Hutton B, Mazzarello S, Clemons M. Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases. Journal of Clinical Medicine. 2013; 2(3):67-88.
Simos, Demetrios; Addison, Christina L.; Kuchuk, Iryna; Hutton, Brian; Mazzarello, Sasha; Clemons, Mark. 2013. "Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases." J. Clin. Med. 2, no. 3: 67-88.